nitroglycerin has been researched along with sirolimus in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Billinger, M; Cocchia, R; Cook, S; Hess, OM; Meier, B; Togni, M; Wenaweser, P; Windecker, S | 1 |
| de Feyter, PJ; Hofma, SH; Lemos, PA; Ligthart, JM; McFadden, EP; Serruys, PW; Sianos, G; van Dalen, BM; van der Giessen, WJ; van Essen, D | 1 |
| Fuke, S; Hioka, T; Kawamoto, K; Maekawa, K; Saito, H; Sato, T; Yoshioka, R | 1 |
| Fuke, S; Hioka, T; Kawamoto, K; Maekawa, K; Ohe, T; Saito, H; Sato, T | 1 |
| Bezerra, HG; Brito, FS; Dantas, JM; Fernandes, RW; Lima, VC; Oliveira, DC | 1 |
| Brugaletta, S; Bruining, N; de Bruyne, B; Dorange, C; Dudek, D; Farooq, V; Garcia-Garcia, HM; Heo, JH; Koolen, J; McClean, D; Onuma, Y; Ormiston, JA; Rapoza, R; Serruys, PW; Smits, PC; van Geuns, RJ; Veldhof, S | 1 |
| Alfonso, F; Bordes, P; Brugaletta, S; Cequier, A; Cuesta, J; García Del Blanco, B; Goicolea, J; Gómez-Hospital, JA; Gomez-Lara, J; Hernández-Antolín, R; Iñiguez, A; Ortega-Paz, L; Romaní, S; Sabaté, M; Salinas, P; Serra, A | 1 |
1 review(s) available for nitroglycerin and sirolimus
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 trial(s) available for nitroglycerin and sirolimus
| Article | Year |
|---|---|
Impaired endothelial vasomotor function after sirolimus-eluting stent implantation.
Topics: Acetylcholine; Aged; Aged, 80 and over; Blood Vessel Prosthesis Implantation; Endothelium, Vascular; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Nitroglycerin; Sirolimus; Stents; Vasoconstriction; Vasodilation; Vasodilator Agents; Vasomotor System | 2007 |
Impact of stenting and oral sirolimus on endothelium-dependent and independent coronary vasomotion.
Topics: Acetylcholine; Administration, Oral; Adult; Analysis of Variance; Coronary Vessels; Endothelium, Vascular; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Nitroglycerin; Sirolimus; Stents; Time Factors; Vasoconstriction; Vasodilation; Vasodilator Agents; Vasomotor System | 2012 |
Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therap
Topics: Absorbable Implants; Acetylcholine; Aged; Coronary Vessels; Drug-Eluting Stents; Endothelium, Vascular; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Ischemia; Nitroglycerin; Plaque, Atherosclerotic; Sirolimus; Tissue Scaffolds; Vasodilation; Vasodilator Agents; Vasomotor System | 2012 |
Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial.
Topics: Absorbable Implants; Acetylcholine; Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Endothelium, Vascular; Female; Humans; Incidence; Magnesium; Male; Middle Aged; Nitroglycerin; Polyesters; Risk Factors; Sample Size; Sirolimus; ST Elevation Myocardial Infarction; Thrombectomy; Tissue Scaffolds; Vasodilation; Vasodilator Agents; Vasomotor System | 2019 |
4 other study(ies) available for nitroglycerin and sirolimus
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction.
Topics: Case-Control Studies; Coronary Angiography; Coronary Disease; Coronary Vessels; Endothelium, Vascular; Exercise; Exercise Test; Female; Hemodynamics; Humans; Immunosuppressive Agents; Male; Middle Aged; Nitroglycerin; Sirolimus; Stents; Time Factors; Vasoconstriction; Vasodilator Agents | 2005 |
Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation.
Topics: Aged; Coronary Angiography; Coronary Restenosis; Coronary Vasospasm; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Nitroglycerin; Prospective Studies; Sirolimus; Stents; Vasodilation; Vasodilator Agents | 2006 |
Images in cardiovascular medicine. Severe endothelial dysfunction after sirolimus-eluting stent implantation.
Topics: Acetylcholine; Adult; Coronary Angiography; Coronary Stenosis; Coronary Vasospasm; Coronary Vessels; Drug Implants; Endothelium, Vascular; Humans; Injections, Intra-Arterial; Male; Myocardial Infarction; Nitroglycerin; Sirolimus; Stents; Vasoconstriction; Vasoconstrictor Agents | 2006 |